Ignoring President Donald Trump’s proposed budget, the Senate is setting up to approve a $2 billion boost in funding for the National Institutes of Health. The…
A major obstacle to in-cell genome editing is, well, the cell itself. “Human cells don’t like to take in stuff,” explained UC Santa Barbara’s Norbert Reich, a…
Vectura unveiled positive results from two phase 2 studies evaluating the ability of young children and toddlers with asthma to use its nebulized inhaler,…
Sensei Biotherapeutics named Ildiko Csiki, M.D., Ph.D., as its new chief medical officer. Csiki was previously VP of immuno-oncology clinical development at…
Salk Institute and Purdue University scientists have discovered the switch in plants that turns off production of terpenoids — carbon-rich compounds that play…
Scientists have pinpointed a key gene that controls segmentation during spider development, which reveals a further similarity to the control of segmentation in…
The Reich Group’s method of light-activated delivery of gene editing enzymes. Credit: University of California – Santa Barbara
A major obstacle to in-cell…
BIO President and CEO Jim Greenwood posted the following op-ed on Linked-In today, making the case for the U.S. Senate to act on legislation that would empower…